Aging Mammary Stem Cells and Breast Cancer Prevention

Research Group(s)

  • Community Oncology and Prevention Trials

Sponsor

LuZhe Sun

Status

Active, not recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT02642094

To examine whether rapamycin can reduce malignant markers and aberrant mammary
stem/progenitor cells (MaSCs) number in surgical specimens

Intervention

Rapamycin

Condition

Cancer of Breast

Investigators

LuZhe Sun, PhD, Ismail Jatoi, MD

See list of participating sites